Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

TIAA

Founders Andrew Carnegie

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$164M
Portfolio companies 18
Rounds per year 0.22
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 10
Key employees 76

Areas of investment

  • Biotechnology
  • Medical Device
  • Health Care
  • Telecommunications
  • Medical
Summary

The main department of described Corporate Investor is located in the New York. The company was established in North America in United States.

Besides them, we counted 76 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the TIAA, startups are often financed by New Enterprise Associates, Weiss, Peck & Greer Venture Partners, ComVentures. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Alta Partners, Montreux Equity Partners. In the next rounds fund is usually obtained by ARCH Venture Partners, Walden International, Venrock.

The real fund results show that this Corporate Investor is 27 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2002. The common things for fund are deals in the range of more than 100 millions dollars. The increased amount of exits for fund were in 2007. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this TIAA works on 13 percentage points more the average amount of lead investments.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Biopharma. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight View, Surface Logix, Traq Wireless.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of TIAA:
Typical Co-investors
TIAA is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after TIAA:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AlleyCorp New York, New York, United States
AppCampus Espoo, Finland, Southern Finland
AWE Funds -
Blue Cloud Ventures New York, New York, United States
ESF Capital England, London, United Kingdom
ForgeHealth Atlanta, Georgia, United States
Gateway Associates Minneapolis, Minnesota, United States
IIFL Seed Ventures India, Maharashtra, Mumbai
Kingfisher Investment Advisors California, San Francisco, United States
Madison Angels Community of Madrid, Madrid, Spain
Philips Healthcare Andover, Massachusetts, United States
Purple Angel Canada, Nepean, Ontario
Remarkable -
Sumitomo Chemical Japan, Tokyo
Suzanne and Walter Scott Foundation -
University of Toronto - The Entrepreneurship Hatchery Canada, Ontario, Toronto
VC Fonds BW -
Yuanlu Investment Management China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CrowdStreet

Commercial Real Estate
Crowdfunding
Financial Services
FinTech
Real Estate
Real Estate Investment
$43M10 Oct 2022 Portland, Oregon, United States

CHER®

FinTech
Marketplace
Real Estate
Social Network
$130K01 Jul 2021 Santa Monica, California, United States

Sientra

Health Care
Medical Device
Pharmaceutical
$85M18 Apr 2007 Santa Barbara, California, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$35M24 Feb 2004 California, United States

Surface Logix

Biopharma
Biotechnology
Health Care
$25M27 Nov 2002 Boston, Massachusetts, United States

Traq Wireless

Mobile Devices
Telecommunications
Wireless
$14M15 Nov 2002 Austin, Texas, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$22M23 Jan 2002 California, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$8M01 Jun 2000 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent TIAA?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 164M
Rounds per year 0.22
Peak activity year 2002
Lead investments 6
Follow on index 0.22
Exits 10
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

CrowdStreet

Commercial Real Estate
Crowdfunding
Financial Services
FinTech
Real Estate
Real Estate Investment
$43M10 Oct 2022 Portland, Oregon, United States

CHER®

FinTech
Marketplace
Real Estate
Social Network
$130K01 Jul 2021 Santa Monica, California, United States

Sientra

Health Care
Medical Device
Pharmaceutical
$85M18 Apr 2007 Santa Barbara, California, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$35M24 Feb 2004 California, United States

Surface Logix

Biopharma
Biotechnology
Health Care
$25M27 Nov 2002 Boston, Massachusetts, United States

Traq Wireless

Mobile Devices
Telecommunications
Wireless
$14M15 Nov 2002 Austin, Texas, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$22M23 Jan 2002 California, United States

NeurogesX

Biotechnology
Medical
Medical Device
Neuroscience
$8M01 Jun 2000 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: